Award

R01AR072213

Funder: National Institutes of Health

Funded outputs count: 2

Funder award ID: R01AR072213

OpenAlex ID: G9000000511

Assessment of Blocking Interleukin-17 Antibodies in Tumor Immunotherapy with Checkpoint Inhibitors or Tumor-Specific T Cells in Implanted and UVB-Induced Cancers

2026 · Yuko Tsuruta, Carlos Alberto Mier-Aguilar, et al. · Biomedicines

Identification of UVB-induced TREM-1–positive tolerogenic dendritic cells and TREM-1 signaling as a target in the prevention of UVB-induced immune suppression and skin carcinogenesis

2025 · Carlos Alberto Mier-Aguilar, Mohammad Asif Sherwani, et al. · Journal of Investigative Dermatology · 1